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Anabasis articulata leaves decoction is widely used by Algerian traditional medicine practitioners as a 
remedy for the treatment of diabetes. The aqueous extract was found to be non-toxic at 1000 mg/kg, as 
no deaths or hazardous signs were recorded during treatment or the observation period (24 and 72 h) in 
either control or treated groups of mice. Experiments were performed in non-diabetic mice, and in 
hyperglycemic mice (glucose treated and alloxan treated mice) to confirm the antidiabetic potential of 
A. articulata. Our results showed that the orally administration at a dose of 400 mg/kg decreased the 
glycaemia by 29.89% after 6 h (p < 0.05), corresponding to the greatest decrease of blood glucose in 
normoglycaemic mice. This dose also lowered blood glucose concentrations in diabetic mice revealing 
antihyperglycemic effect of A. articulata leaves. The class of phytochemical responsible for antidiabetic 
effects in aqueous leaf extract was also investigated. Phytochemical screening showed that the 
aqueous extract contains alkaloids (1.25%) and saponin (1.30%). Our findings showed that saponin (5 
mg/Kg) was the active fraction, since it restores the normal blood glucose levels after 21 days of 
treatment. The alkaloid fraction did not significantly reduce the blood glucose level. The present study 
confirms the antidiabetic proprieties of A. articulata leaves previously reported by Algerian healers. 
 





Diabetes is a serious complex chronic condition that is a 
major source of ill health worldwide. The number of 
people in the world with diabetes has increased drama-
tically in recent years. Indeed, by 2010 it has been 
estimated that the diabetic population will increase to 221 
million around the world (Carter, 2004). In some parts of 
the world, before the advent of insulin injections and 
other pharmaceutical preparations, healers relied heavily 
upon medicinal plants and herbs to treat diabetes. In this 
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be experimentally or ethnopharmacologically used in the 
treatment of diabetes (Aida et al., 1990; Hur, 1999; 
Alarcon-Aguilara et al., 1998; Sepici et al., 2004; Kang et 
al., 2005). Currently, a few of these medicinal plants have 
received scientific or medical scrutiny, despite the fact 
that the World Health Organization (WHO, 2006) has 
encouraged and recommended that traditional treatment 
for diabetes warrant further evaluation.  
Algeria has a rich heritage of medicinal plants of wide 
diversity which are prescribed by the traditional healers to 
treat several diseases including diabetes and cardio-
vascular diseases (Bellakhdar et al., 1991; Ziyyat et al., 
1997; Eddouks et al., 2002). Anabasis articulata locally 
named as ‘ajrem’ is a wild plant  widely  used  in  Algerian  




traditional medicine to treat diabetes, fever, headache 
and skin diseases such as eczema (Hmamouchi, 1999; 
Hammiche et al., 2006). Its is taken orally after decoction 
in water as a single herb or with other medicinal plants. 
No scientific investigations concerning the pharmacolo-
gical properties of A. articulata has been done.  
 The phytochemical constituents of A. articulata 
revealed the presence of saponin. Among them triterpe-
noid saponin glycosides have been isolated and identified 
(Sandberg and Shalaby, 1960; Sandberg and Michel, 
1962; Segal et al., 1969). Literature data indicates that 
some saponin isolated from medicinal plants significantly 
reduces blood glucose levels (Gina et al., 1989; Cherian 
et al., 1992; Nakashima et al., 1993; Petit et al., 1995; 
Zarzuelo et al., 1996; Nojima et al., 1998; Abdel-Hassan 
et al., 2000; Abdel-Zaher et al., 2005). Several biological 
activities have been attributed to saponin such as their 
immuno-stimulant effect (Estrada et al., 2000), 
cytotoxicity (Zou et al., 2000; Heisler et al., 2005) and 
antitumoral properties (Zheng et al., 2006). 
The present study was conducted to confirm the anti-
diabetic effect of A. articulata leaves previously reported 
by Algerian healers. 
 
 




The leaves of A. articulata are collected from local inhabitants 
having knowledge of the curative properties of this plant in Septem-
ber 2006. The plant materials were identified and authenticated with 
assistance of Prof. Hadjadj-Aouls, M.S (Botanic Department, Oran, 
Algeria). Voucher specimen of this plant was deposited in the 





All chemicals were purchased from Sigma (USA), Aldrich (Milwau-
kee, USA), Fluka (Buchs, Switzerland) and Merck (Germany). 
 
 
Preparation of aqueous extracts 
 
Plant material was prepared according to the traditional method 
used in Algeria (decoction): 100 g of powdered aerial parts mixed 
with 2 L distilled water were boiled for 10 min and then cooled for 
15 min and filtered. The filtrate was then freeze-dried to give 17.50 
g of a brown extract powder and the desired dose (mg of lyophilized 
aqueous extract per kg body weight) was then prepared and 
reconstituted in 10 ml of distilled water.  
The active aqueous fraction was subjected to chemical analysis 
to determine the class of compounds present in it (Trease and 
Evans, 1983). This fraction was tested for the presence of alkaloids 
(Dragendorff reagent and Mayer’s reagent), steroids (Liebermann–
Buchard test), and saponin.  
 
 
Preparation of the crude alkaloid fraction 
 
The alkaloid extract was obtained by an acid/basic modified 
extraction as described by Ott-Longoni et al. (1980), with minor 





and the air-dried plant material (500 g) was extracted three times 
with hexane (2 L/kg) for 48 h at room temperature with occasional 
shaking to eliminate apolar constituents. The extract was then 
filtered and the residue was flooded with methanol (1.5 L/kg) using 
the above process. The methanol extract was then concentrated 
under reduced pressure and acidified with 0.5 M H2SO4. The acidic 
extract was washed with chloroform to remove neutral components. 
The aqueous acidic fraction was then made basic with ammonia 
(pH 10) and extracted again with chloroform until the aqueous layer 
was free of alkaloids. The combined chloroform extracts were 
evaporated in vacuo to yield the crude alkaloid fraction as a brown 
residue (1.25% w/w of the dry starting material). This extract was 
developed by chromatography in a thin layer silica gel chromato-
graphy using chloroform/methanol (8:2) as a solvent system. Later, 
plates were air-dried, observed under UV light, sprayed with 




Extraction of saponin 
 
Saponins, contained in the leaves of A. articulata (100 g) were 
extracted with methanol in Soxhlet apparatus (Estrada et al., 2000). 
The extract was concentrated, freeze-dried and re-extracted with 
water and butanol saturated with water. The dried crystalline 
butanolic extract (1.3 g) was obtained. Thin layer chromatographic 
analysis was performed with the method of Wagner and Bladt 
(1996). The developing solvent was n-butanol : acetic acid : water 
(40:10:50). The butanolic crystalline extract was dissolved in the 
developing solvent and applied to aluminum-backed plates coated 
with silica gel 60 F254 (layer thickness 0.2 mm, 20x20 cm; E. Merck, 
Darmstadt, Germany). After development, plates were air-dried, 
observed under UV light, sprayed with methanol : acetic acid : 
sulphuric acid : anisaldehyde (85:10:5:0.1) and heated at 100°C for 






9 weeks old Swiss albino mice (10) ranging in weight from 40 – 45 
g were used. The animals were housed with a 12 h light : 12 h dark 
schedule with free access to water and food (SDS Dietex-France) 
and maintained at a constant temperature (21 ± 2°C) and a relative 
humidity of 55 ± 10%. All animal procedures were carried out in 
accordance with the European Community Council Directive of 24 
November 1986 (86/609/EEC). 
 
 
Toxicity evaluation in mice 
 
To study sub-acute (short term) toxicity, four groups of mice were 
used and were orally fed with the aqueous extract of A. articulata in 
increasing dose levels of 100, 500, 1000 mg/kg body weight. The 
animals were observed after 30 min and 2 h. The following profiles 
were observed (Turner, 1965). Behavioural profile: alertness, 
restlessness, irritability, and fearfulness. Neurological profile: 
spontaneous activities, reactivity, touch response, pain response 





Ability of the extract to lower blood glucose, in the normal or the 
hyperglycemic animals, reflects its hypoglycaemic effect. The 
animals were fasted for 6 h prior to the collection of blood for 
glucose estimation, though water was allowed ad libitum during this 





aqueous extract containing, saponin and alkaloids were adminis-
tered orally in the different doses (100 - 500 mg/Kg). The percen-
tage change in the plant induced glycemia was calculated as a time 
function by applying the formula below: 
 
[(Gi − G0)/G0] ×100    [Dinesh, 2001] 
 
G0 is the initial glycemia and Gi is glycemia at the ‘i’ h (I = 1, 2 or 6 
h). This parameter was used as an index of the hypoglycemic 
activity. 
Dose-response was studied with reference to hypoglycemia by 
single oral administration of different doses (100 - 500 mg/Kg) of 
the aqueous extracts, saponin (5 mg/Kg) and alkaloids (5 mg/Kg). 
Blood samples for glucose estimation were collected after 1, 2 and 
6 h intervals. The above doses were used for screening the hypo-
glycaemic action of the leaf extract in the normal (normoglycemic) 
mice. The control mice (negative control) were orally administered 
with vehicle (distilled water). All blood samples were collected from 
the caudal incision. 
 
 
Glucose induced antihyperglycemic mice 
 
Mice fasted for 6 h were given glucose (10% solution) at a dose of 
3 g/kg. The extracts (aqueous extract: 400 mg/Kg, saponin: 5 
mg/Kg and alkaloids: 5 mg/Kg) were given to the fasted animals, 
and 30 min after treatment the above glucose load was given. 
Blood samples were obtained for the glucose estimation at the 
same time intervals 1, 2 and 6 h after the glucose loading. The 
mean glucose tolerance test (GTT), so obtained after the treatment, 
was compared with the pre-treatment. The activity was assessed 
quantitatively by the improvement in the GTT response. The per-
centage change in the plant induced glycemia was calculated by 
the preceding formula (above). 
 
 
Induction of alloxan diabetes 
 
The mice were kept in a fasting state for at least 6 h and then 
rendered diabetic by injecting alloxan intraperitoneally (200 mg/kg). 
Seven days after the administration, the animals with fasting 
plasma glucose of 200 mg/dl, or more, were classified as diabetic 
and were included in the study. 
Animals were divided into seven groups of six mice each. The 
extract was administered for 21 days. Group I: normal control mice 
administered water daily; Group II: diabetic control mice no treated; 
Group III: diabetic mice administered aqueous extract (500 mg/kg); 
Group IV: diabetic mice administered aqueous extract (400 mg/kg); 
Group V: diabetic mice administered saponin extract (5 mg/kg); VI: 
diabetic mice administered alkaloids extract (5 mg/kg); Group VII: 
diabetic mice administered reference drug glibenclamide (10 
mg/kg). The effects of administration of leaves aqueous extract to 
normal and diabetic mice were determined by measuring fasting 
plasma glucose levels (Nicholas, 1956) and initial and final changes 
in body weight. Day 7 of induction was designated as day 1 for 
extract administration in diabetic mice. Fasting plasma glucose was 
estimated on days 7, 14, and 21 of extract administration and the 





All the data reported were expressed as mean ± S.E.M. Statistical 
analyses were performed using Wilcoxon test. The values were 
considered to be significantly different when the p value was less 
than 0.05 compared to the respective control. Statistical analyses 
were carried out using the Statview® 4.5 statistical package 
(Abacus Concepts, Inc). (Borenstein et al., 1997).  






Preliminary chemical screening 
 
The qualitative chemical analysis of the aqueous extract 
of A. articulata showed that preliminary alkaloid tests 
were positive for both tertiary and quaternary alkaloids 
according to Mayer’s and Dragendorff’s reagents. 
Moreover, the screening for saponin component showed 
positive results with FeCl2 and HgCl2. 
The quantitative chemical analysis exhibited the 
presence of alkaloids and saponin with percentage 1.25 
and 1.30%, respectively. After development of butanol 
extract in plates of silica gel and observed under UV light, 
four saponin glycosides were detected; saponin bands 
turned red and were readily visualized. 
 
 
Toxicity evaluation in mice 
 
No deaths or hazardous signs were recorded during 
treatment or the observation period (24 and 72 h) in 
either control or treated groups of mice with aqueous 





As shown in Table 1 a dose-response study was carried 
out. Indeed, different doses of the leaf extract were orally 
administered and falls in plasma glucose levels were 
observed. Administration of the extract at a dose of 100 
mg/kg brought about fall in fasting plasma glucose from 
95.6 ± 4.03 to 83 ± 4.71. (12% fall) at 6 h. A dose of 200 
mg/kg improved the response by producing a more 
significant fall of 15.8% at 6 h. Thus, of the four doses 
tried, a dose of 400 mg/kg caused the greatest decrease 
in the blood glucose (29.87% fall at 6 h). However, further 
increase in the dose (500 mg/kg) did not improve the 
hypoglycemic response (17.66% fall at 6 h).  
 
 
Glucose induced hyperglycemic mice 
 
The mean blood glucose levels of fasted hyperglycaemic 
animals at 2, 4 and 6 h after oral administration of 
aqueous extract, alkaloids and saponin fraction are 
shown in Table 2. 
In the glucose-induced diabetic mice, treatment with a 
dose of the 400 mg/kg of the extract to animals caused a 
fall of fasting plasma glucose (118.25 ± 0.85 mg/dl): the 
post-treatment values at 2, 4 and 6 h were 139.25 ± 6.11, 
105.75 ± 5.64, and 105.00 ± 5.4 mg/dl, respectively. The 
percent of glycemic falls relative to the fasting plasma 
glucose were 10.55 and 11.19% at 4 and 6 h, respec-
tively, which are significant (p < 0.05) and indicate a 
noteworthy hypoglycemic response at 6 h (Table 2). No 
such   antihyperglycemic   effect   was observed in  crude  




   Table 1. Dose-response effect of the leaves of A. articulate on plasma glucose values in the normoglycemic mice at 6 h. 
 
Treatment Pre-treated Post-treated Percentage 
Control 76.8 ± 1.15 76.4 ± 3.58 -5.24 
100 mg/Kg 95.60 ± 4.03 83.0 ± 4.71 -12 
200 mg/Kg 85.0 ± 0.44 71.4 ± 3.5 * -15.96 
400 mg/Kg 91.20 ± 0.58 64.00 ± 3.43 ** -29.87 
500 mg/Kg 83.4 ± 1.5 68.4 ± 4.61 * -17.66 
 
Plasma glucose values are given as means ± SE in mg/dl. The negative value (−) indicates a decrease in glycemia.  




Table 2. Mean plasma glucose values before and after admistration of the A. articulata leaves, saponin and alkaloids in the oral glucose 
tolerance in mice. 
 
Treatment Fasting 2 h Change (%) 4 h Change (%) 6 h Change (%) 
400 mg/kg 118.25 ± 0.85 139.25 ± 6.11 +17.72 105.75 ± 5.64 * -10.55 105.00 ± 5.4 * -11.19 
Saponin (5 mg/kg) 110.8 ± 1.02 167.4 ± 7.34 +51.19 93.6 ± 1.93 * -15.53 90.4 ± 3.14 * * -18.44 
Alkaloids (5 mg/kg) 100.2 ± 1.85 127.6 ± 8.91 +27.44 107.8 ± 4.39 * +7.65 101.0 ± 5.27 * +0.61 
Control 85.4 ± 2.76 161 ± 23.6 +89.98 114.2 ± 3.8 +34.69 104.8 ± 1.96 +23.04 
 




alkaloids and the control group of mice after 4 h. The 
alkaloid extract did not significantly lower the fasting of 
glucose levels from 100.2 mg/dl at 0 h to 101 mg/ dl ml 
after 6 h. 
The effects were more pronounced with saponin 
extract, which significantly (P < 0.05) lowered the fasting 
glucose levels after 4h, highly significant (P < 0.01) after 
6 h. The percent of glycemic falls relative to the fasting 
plasma glucose were 15.53 and 18.44%, respectively at 
4 and 6 h. 
 
 
Induction of alloxan diabetes 
 
As shown in Table 3, in the alloxan-induced diabetic 
mice, glibenglamide at 10 mg/kg i.p decreased the levels 
of hyperglycemia in 44.06 and 71.99%, after 15 and 21 
days, respectively, of diabetes treatment. The aqueous 
extract at the dose of 400 mg/kg was found to reduce the 
increase of blood glucose levels in 45.23 and 74.48 % at 
15 and 21 days, respectively. The saponin fraction at a 
dose of 5 mg/kg showed a maximum decrease (76.00%) 
in the blood glucose level in the diabetic mice after D+ 21 
treatments. However, the treatment with the crude extract 
of alkaloids at same concentration of saponin (5 mg/kg) 
did not show any decrease in glycemia on the blood 
glucose level. After the treatment, the percentage change 
was increased in D+21 (4.95%). This variation indicates the 
absence of significant antihyperglycemic response in the 





A. articulata extract was tested at  several  doses  in  nor- 
moglycemic mice, and its dose-response showed that the 
maximum hypoglycaemic effect was found with the dose 
of 400 mg/kg (Table 1). Besides the hypoglycaemic 
effect, our results indicate that aqueous extract of A. 
articulata reduces the hyperglycemia level and improves 
glucose tolerance in both glucose diabetic mice and 
alloxan diabetic mice (severe diabetic mice) revealing the 
antihyperglycemic effect of this medicinal plant. Indeed, 
400 mg/kg of extract resulted to the reduction of 
hyperglycemia levels in glucose induced hyperglycemic 
mice after 4 h of treatment (Table 2). The daily treatment 
with this dose for 21 days brought also fasting plasma 
glucose to near normal range in severe diabetic animals 
(Table 3). Moreover, the saponin fraction (5 mg/kg) 
displayed antihyperglycemic effect in oral glucose 
tolerance test, and exhibited the almost same effect as 
the well-known antidiabetic glibenclamide (10 mg/kg) in 
alloxan diabetic mice. However, the alkaloid extract did 
not significantly lower the blood glucose levels compared 
with control after treatment in diabetic mice. 
The results obtained clearly show that the aqueous 
extract of A. articulata leaves possess an antidiabetic 
effect. Phytochemical analysis showed that the major 
chemical constituents of the extract were alkaloids and 
saponin. In the light of our findings, the antidiabetic 
activity of A. articulata could be attributed to saponin 
components since alkaloids did not present any effect on 
hyperglycemia levels, whereas aqueous extract and 
saponin had the nearly similar effects in diabetic mice.  
The antihyperglycemic activity of A. articulata is 
through the release of insulin from the pancreas that is, it 
exerts a direct insulinotropic effect, or it could also be due 
to the insulin like effect of the active principle (saponin) 




Table 3. The effect of 3-week treatment with various doses of aqueous extract of A. articulata, saponin and Alkaloids extract on glucose levels  in alloxan 
diabetic mice. 
 
Treatment D-7 D0 D+7 Percent change D+14 Percent change D+21 Percent change 
Control 82.5 ± 4.97 82.66 ± 4.57 81.83 ± 5.02 1.16 ± 0.98 82.16 ± 4.95 0.63 ± 0.57 82.00 ± 4.97 0.86 ± 1.64 
Diabetic N.T.  91.00 ± 6.36 281.66 ± 4.51 309.88 ± 4.66 +10.09 ± 2.02 383.00 ± 5.36 +36.09 ± 2.28 389.8 ± 5.43 +38.55 ± 2.73 
500 mg/Kg 85.14 ± 3.48 245.85 ± 6.81 286.85 ± 5.87* +17.24 ± 4.30 258.14 ± 12.89* +5.07 ± 4.49 199.57 ± 2.59* -18.40 ± 2.74 
400 mg/Kg 94.50 ± 3.09 367.16 ± 4.04 338.50 ± 3.70* -7.63 ± 2.23 200.83 ± 1.60* -45.23 ± 0.91 93.50 ± 6.60* -74.48 ± 1.88 
Saponin 86.83 ± 4.86 365.66 ± 2.47 335.16 ± 2.04* -8.31 ± 0.99 195.33 ± 2.52* -46.58 ± 0.56 87.66 ± 4.44* -76.00 ± 1.28 
Alkaloids 85.0 ± 3.88 254.5 ± 4.21 306.28 ± 2.81* +20.52 ± 2.34 295.42 ± 13.45* +16.03 ± 4.79 266.57 ±6.22 +4.95 ± 3.32 
Glibenclamide 101 ± 3.88 353.16 ± 8.95 331.16 ± 8.32* -6.17 ± 1.48 196.83 ± 1.90* -44.06 ± 1.66 98.16 ± 4.52* -71.99 ± 1.81 
 
The values are expressed as means ± S.E.M, n = 6 mice per group. 
Percentage change indicates the percentage lowering of plasma sugar in comparison to the reading at J0.  
The negative value (−) indicates a decrease in glycemia of control diabetic animal treated with water.  
*P < 0.05, when compared to the baseline values.  




present in the extract. Our results confirm the 
antidiabetic proprieties of A. articulata leaves 
previously reported by Algerian healers. However, 
chemical and pharmacological investigations are 
necessary to isolate and elucidate the structure of 
the saponin and to confirm its mechanism of 
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